{"id":"NCT04157686","sponsor":"Medy-Tox","briefTitle":"MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)","officialTitle":"A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-23","primaryCompletion":"2023-02-16","completion":"2023-02-16","firstPosted":"2019-11-08","resultsPosted":"2024-08-09","lastUpdate":"2024-08-09"},"enrollment":957,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Glabellar Lines","Lateral Canthal Lines"],"interventions":[{"type":"DRUG","name":"MT10109L Dose 1","otherNames":[]},{"type":"DRUG","name":"MT10109L Dose 2","otherNames":[]},{"type":"DRUG","name":"MT10109L Dose 1 + Dose 2","otherNames":[]}],"arms":[{"label":"Placebo/MT10109L Dose 1","type":"EXPERIMENTAL"},{"label":"Placebo/MT10109L Dose 2","type":"EXPERIMENTAL"},{"label":"Placebo/MT10109L Dose 1 + Dose 2","type":"EXPERIMENTAL"},{"label":"MT10109L Dose 1/Dose 1","type":"EXPERIMENTAL"},{"label":"MT10109L Dose 2/Dose 2","type":"EXPERIMENTAL"},{"label":"MT10109L Dose 1/Dose 1+2","type":"EXPERIMENTAL"},{"label":"MT10109L Dose 2/Dose 1+2","type":"EXPERIMENTAL"},{"label":"MT10109L Dose 1+2/Dose 1+2","type":"EXPERIMENTAL"}],"summary":"To evaluate the long-term safety of MT10109L in the treatment of GL and/or LCL in participants with moderate to severe GL and/or LCL.","primaryOutcome":{"measure":"Number of Participants Who Experienced Any Adverse Event (AE)","timeFrame":"Baseline to Day 720 or Study Exit","effectByArm":[{"arm":"Placebo/MT10109L Dose 1","deltaMin":39,"sd":null},{"arm":"Placebo/MT10109L Dose 2","deltaMin":39,"sd":null},{"arm":"Placebo/MT10109L Dose 1 + Dose 2","deltaMin":80,"sd":null},{"arm":"MT10109L Dose 1/Dose 1","deltaMin":89,"sd":null},{"arm":"MT10109L Dose 2/Dose 2","deltaMin":74,"sd":null},{"arm":"MT10109L Dose 1/Dose 1+2","deltaMin":80,"sd":null},{"arm":"MT10109L Dose 2/Dose 1+2","deltaMin":89,"sd":null},{"arm":"MT10109L Dose 1+2/Dose 1+2","deltaMin":183,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":38,"countries":["United States","Belgium","Canada","Germany","Russia","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":55},"commonTop":["COVID-19","Nasopharyngitis","Headache","Injection site pain","Upper respiratory tract infection"]}}